Our proof-of-concept study for using VAR2-technology to detect and quantify oncofetal chondroitin sulfate in urine from bladder cancer patients as an indication of disease was published today. #VAR2diagnostics#VAR2#VanProstateCtr#cancerdiagnostics
https://t.co/PTC4ljiSND
Dr. Mads Daugaard is looking for a new postdoctoral research fellow to join his academic work on VAR2-based immunotherapy. #CancerResearch#Immunotherapy
I am looking for a skilled and motivated postdoc to help advance our research on VAR2-based bi-specific immune engagers in sarcomas towards the clinical arena. https://t.co/XfpGanguji #translationalresearch#cancerresearch#immunotherapy
We are hiring!!! Check this link if you would like to work on mitochondria and advanced microscopy in an international and collaborative atmosphere 😊 https://t.co/30Cxc1WRDu
We're excited to announce that @Var2Pharma was selected as the European winner of our 2020 Advance Biotech Grant Program. VAR2 Pharmaceuticals developed a novel cancer treatment that has the potential to treat multiple types of human tumors. Learn more: https://t.co/iGYoVTEHMb
Two of our very own have been recognized for their outstanding work: Poul Sorensen for been nominated as a finalist for the 2019 Bloom Burton Award, and Mads Daugaard being awarded the St. Baldrick’s Foundation One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery.
Two of our very own have been recognized for their outstanding work: Poul Sorensen for been nominated as a finalist for the 2019 Bloom Burton Award, and Mads Daugaard being awarded the St. Baldrick’s Foundation One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery.
Congratulations to Dr. Mads Daugaard and Dr. Adam Shlien on receiving the St. Baldrick's Foundation Robert. J. Arceci Innovation Award! Each will receive $125,000 a year, for three years, to support their innovative work focused on fighting #pediatriccancers.
We are very happy for our very own Mads Daugaard on being awarded the St. Baldrick’s Foundation One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery. Great job Mads! https://t.co/18aUaUsqSB
Risikovillige forskningsinvesteringer sætter skub i forskningens fødekæde. Følg investeringskæden fra malariaforsker Ali Salantis ph.d.forskning i 2001 til test af en vaccine mod graviditetsmalaria og forskningen i #Cancer@Var2Pharma@UCPH_health @Innofond #forskpol#dkforsk
An interesting Forum by Dr. Ali Salanti and colleagues highlighting the function of recombinant #malaria protein VAR2CSA in #cancer diagnostics and therapeutics @Var2Pharma@uni_copenhagen
Free Download for limited time: https://t.co/vJD1dwDjU6
https://t.co/PzrYxFzmPV
A great story about one of our founders:
In 1998, Poul Sorensen’s lab discovered a cancer mutation. Twenty years later, there’s a drug for it. $LOXO #cancer#CancerResearch https://t.co/xLGqtCIkwE
A great story about one of our founders:
In 1998, Poul Sorensen’s lab discovered a cancer mutation. Twenty years later, there’s a drug for it. $LOXO #cancer#CancerResearch https://t.co/xLGqtCIkwE